Hims & Hers can't sell off-brand Ozempic forever, but it can still sell these weight-loss meds
Hims & Hers (HIMS) made a killing last year selling an off-brand version of Ozempic, but with the drug’s shortage now over, ...
ConsumerAffairs25m
Hims & Hers withdraws from Wegovy, Ozempic market
Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...
StockStory.org on MSN58m
Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 27.6% in the afternoon session after the company delivered mixed fourth-quarter 2024 results: It added fewer customers than expected, ...
Hosted on MSN40m
Stock Market Today: Dow Jones Clings To Gain; Robinhood Looks To Extend Losing Streak (Live Coverage)
The Dow Jones index pulled ahead as the other major indexes fell on the stock market today. Hims & Hers and Robinhood both ...